J L Ferrero

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations

Life Sciences, Neurology, Neuroscience +14

First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease

J L Ferrero, Leslie Williams, Heather Stella et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2016 · 181 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth:  Design, Synthesis, and Optimization of Pharmacokinetics and Biological Activities

Fortuna Haviv, Michael F. Bradley, Douglas Kalvin et al. · Journal of Medicinal Chemistry · 2005 · 138 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +14

Metabolism and disposition of clarithromycin in man.

J L Ferrero, Barbara A. Bopp, Kennan C. Marsh et al. · Drug Metabolism and Disposition · 1990 · 136 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +8

In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.

A. David Rodrigues, Darcy J. Mulford, R D Lee et al. · Drug Metabolism and Disposition · 1995 · 70 citations

Medicine, Biochemistry, Pharmacology +17